Inhalac 70
Dry powder inhalants are often used in the pulmonary route of administration. Its advantages include excellent ease of use, small size for portability, and no precise fit (relative to aerosol) between device excitation and patient breathing. In addition, because it does not contain Freon, it is more environmentally friendly. In use and storage, solid dosage forms have better physicochemical stability. Dry powder inhalants generally consist of a device, drugs and auxiliaries. Additives are added to ensure a smooth production process. Therefore, the particle properties of powders related to the process are important factors that need to be paid attention to in the design of prescriptions.
InhaLac® 70 from Meggle's InhaLac® series is a coarse-grained lactose with a typical median value of 210 microns, which is essentially free of fine powder particles (particles <15μm). In addition, its particle size distribution is very narrow (peak width to height ratio 0,8), which is most suitable for device design based on the tornado effect.
previous item: Inhalac 400
next item: Inhalac 120





关闭返回